A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients

Completed · Phase 4 · Has a placebo group

Conditions studied: Hypertension

In brief

This study will evaluate the efficacy and safety of nebivolol monotherapy in Hispanic patients with stage 1 or stage 2 hypertension

Key facts

Study ID

NCT00770861

Run by

Forest Laboratories

People needed

277

Starts

2008-09-01

Last updated by the study team

2011-01-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female outpatients 18 to 80 years of age, self-identified as Hispanic or Latino ethnicity
• Females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
• Meet criteria for stage I or II hypertension
• Currently not treated, or being treated with no more than two anti-hypertensive medications

You may not qualify if…

• Secondary hypertension
• Are taking three or more antihypertensive agents
• Have uncontrolled or poorly controlled diabetes mellitus type I or type II
• Evidence of other concurrent disease or conditions that might interfere with the conduct of the study
• Participation in any investigational study within 30 days of Screening (Visit 1).
• Have a history of hypersensitivity to nebivolol or other β-blockers, or any contraindication to β-blocker use

Where it is running

• Forest Investigative Site — Buena Park, California, United States
• Forest Investigative Site — Chino, California, United States
• Forest Investigative Site — Long Beach, California, United States
• Forest Investigative Site — Los Angeles, California, United States
• Forest Investigative Site — National City, California, United States
• Forest Investigative Site — San Bernardino, California, United States
• Forest Investigative Site — Temecula, California, United States
• Forest Investigative Site — Tustin, California, United States
• Forest Investigative Site — Coral Gables, Florida, United States
• Forest Investigative Site FL2 — Hialeah, Florida, United States
• Forest Investigative Site — Hialeah, Florida, United States
• Forest Investigative Site — Hialeah, Florida, United States
• Forest Investigative Site — Kissimmee, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Pembroke Pines, Florida, United States
• Forest Investigative Site — Pembroke Pines, Florida, United States
• Forest Investigative Site — West Palm Beach, Florida, United States
• Forest Investigative Site — Atlanta, Georgia, United States
• Forest Investigative Site — Atlanta, Georgia, United States
• Forest Investigative Site — New Windsor, New York, United States
• Forest Investigative Site — The Bronx, New York, United States
• Forest Investigative Site — Carrollton, Texas, United States
• Forest Investigative Site — Corpus Christi, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.